CAGRILINTIDE (10mg)
CAGRILINTIDE is a next-generation amylin analogue currently under investigation for its synergistic effects when combined with GLP-1 receptor agonists. It has gained strong interest in metabolic and obesity research for its potential role in amplifying satiety signaling, reducing caloric intake, and enhancing long-term weight regulation.
In controlled research models, CAGRILINTIDE has been associated with:
-
Significant additional body weight reduction when co-administered with GLP-1 receptor agonists
-
Improved appetite suppression and extended satiety compared to GLP-1 agonists alone
-
Favorable effects on energy balance and body composition metrics
Atlas Compounds provides CAGRILINTIDE as a 10mg lyophilized peptide, with confirmed purity ≥99% via HPLC.
Care & Maintenance
Store all peptides in a cool, dry place away from direct sunlight and heat.
Unreconstituted vials are best kept refrigerated at 2–8 °C.
Once reconstituted with bacteriostatic water, peptides must be stored in the refrigerator and used within 90 days.
Always handle vials with clean hands and sterile equipment to prevent contamination. Do not shake the vial—gently swirl to dissolve the powder.
If you notice any discoloration, cloudiness, or clumping, discard the vial immediately.
Intended Use
This product is strictly for laboratory research, education, and development purposes only.
Terms of Sale
By purchasing or handling this compound, you acknowledge that you are a qualified researcher or institution aware of the proper safety protocols.
Atlas Compounds assumes no liability for any misuse, mishandling, or off-label application of this product.
Disclaimer
All information provided is for educational and scientific reference only. Buyer assumes all responsibility for lawful use and compliance with applicable regulations.
